SCHEMBL6227951

SCHEMBL6227951

O=c1cc[nH]c(=O)n1N1CCOCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK3 P52333 2/20 0.36
▸ PIK3R1 P27986 1/20 0.36
▸ PIK3CA P42336 1/20 0.36
▸ APOBEC3G Q9HC16 1/20 0.34
▸ HSD17B10 Q99714 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ ELANE P08246 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ EP300 Q09472 1/20 0.33
▸ KAT2B Q92831 1/20 0.33
▸ JAK2 O60674 1/20 0.32
▸ JAK1 P23458 1/20 0.32
▸ PRKDC P78527 1/20 0.32
▸ BCHE P06276 1/20 0.32
▸ POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3500363 0.67 CA12 (0.46) PIK3R1PIK3CASMN1; SMN2MAPTHPGD
SCHEMBL28024737 0.63 PRKDC (0.51) JAK3PIK3R1PIK3CAHSD17B10ALDH1A1
Fluoride SCHEMBL27679532 0.62 BRD4 (0.31) —
SCHEMBL22150604 0.61 PIK3CA (0.49) PIK3CAALDH1A1MAPTKMT2AEP300
SCHEMBL6227943 0.61 CRBN (0.41) HSD17B10ALDH1A1KMT2ATSHRGAA
SCHEMBL9443401 0.61 CRBN (0.41) —
SCHEMBL942469 0.60 PIK3CB (0.51) JAK3PIK3R1PIK3CASMN1; SMN2KMT2A
SCHEMBL17906986 0.59 PRKDC (0.42) SMN1; SMN2ALDH1A1MAPTHPGDKMT2A
SCHEMBL438291 0.59 — —
SCHEMBL3763 0.59 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118994133-A Morpholino nucleoside monomer full-flow synthesis process based on unprotected ring expansion strategy 浙江大学 2024-11-22 — — CN disclosed
EP-0973886-B1 METHOD AND CONJUGATE FOR TREATING HELICOBACTER PYLORI INFECTIONS AVI BIOPHARM INC (US) 2005-03-23 — — EP disclosed
US-6124271-A ANTISENSE CONJUGATE STABLE TO STOMACH ENVIRONMENT AND COMPOSED OF AN UPTAKE FACILITATING TRANSPORT MOIETY CONJUGATED TO A NUCLEASE-RESISTANT ANTISENSE OLIGOMER WHICH BASE-SPECIFICALLY BINDS TO H. PYLORI MRNA TRANSCRIPT AVI BIOPHARMA, INC. 2000-09-26 — — US disclosed
US-6030941-A FOR DELIVERY OF DRUGS AND OTHER COMPOUNDS ACROSS LIPID LAYERS AVI BIOPHARMA, INC. (US) 2000-02-29 — — US disclosed
Send feedback